[go: up one dir, main page]

DK1218037T3 - In vivo-assay til testning af den fænotypiske stabilitet - Google Patents

In vivo-assay til testning af den fænotypiske stabilitet

Info

Publication number
DK1218037T3
DK1218037T3 DK00967443T DK00967443T DK1218037T3 DK 1218037 T3 DK1218037 T3 DK 1218037T3 DK 00967443 T DK00967443 T DK 00967443T DK 00967443 T DK00967443 T DK 00967443T DK 1218037 T3 DK1218037 T3 DK 1218037T3
Authority
DK
Denmark
Prior art keywords
chondrocytes
vivo assay
outcome
phenotypic stability
stability
Prior art date
Application number
DK00967443T
Other languages
Danish (da)
English (en)
Inventor
Frank Luyten
Bari Cosimo De
Accio Francesco Dell
Original Assignee
Tigenix Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tigenix Nv filed Critical Tigenix Nv
Application granted granted Critical
Publication of DK1218037T3 publication Critical patent/DK1218037T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0004Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0006Skin tests, e.g. intradermal testing, test strips, delayed hypersensitivity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0004Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0004Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DK00967443T 1999-10-06 2000-10-06 In vivo-assay til testning af den fænotypiske stabilitet DK1218037T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99203273 1999-10-06
EP00967443A EP1218037B1 (en) 1999-10-06 2000-10-06 In vivo assay for testing the phenotypic stability

Publications (1)

Publication Number Publication Date
DK1218037T3 true DK1218037T3 (da) 2005-04-25

Family

ID=8240723

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00967443T DK1218037T3 (da) 1999-10-06 2000-10-06 In vivo-assay til testning af den fænotypiske stabilitet

Country Status (12)

Country Link
US (2) US7479367B1 (pt)
EP (2) EP1498146A3 (pt)
AT (1) ATE285797T1 (pt)
AU (1) AU7764200A (pt)
CA (1) CA2397610C (pt)
CY (1) CY2010007I1 (pt)
DE (3) DE20023659U1 (pt)
DK (1) DK1218037T3 (pt)
ES (2) ES2488240T1 (pt)
LU (1) LU91672I2 (pt)
PT (1) PT1218037E (pt)
WO (1) WO2001024833A2 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1218037E (pt) * 1999-10-06 2005-05-31 Tigenix Nv Ensaios in vitro e marcadores moleculares para testar a estabilidade fenotipica de populacoes de celulas, e populacoes de celulas seleccionadas para transplantacao autologa
US7482114B2 (en) 1999-10-06 2009-01-27 Tigenix N.V. In vivo assay and molecular markers for testing the phenotypic stability of cell populations, and selected cell populations for autologous transplantation
AU2001266915A1 (en) 2000-06-14 2001-12-24 Case Western Reserve University Probes for chondrogenesis
WO2004013606A2 (en) * 2002-08-02 2004-02-12 Stratatech Corporation Species specific dna detection
NZ589814A (en) 2006-03-20 2012-03-30 Tigenix Nv Methods to maintain, improve and restore the cartilage phenotype of chondrocytes
US20100068715A1 (en) * 2006-11-24 2010-03-18 Tigenix N.V. Marker genes for use in the identification of chondrocyte phenotypic stability and in the screening of factors influencing cartilage production
CN101215565B (zh) * 2008-01-11 2011-04-27 华中农业大学 一种作为猪标记辅助选择的与免疫性状相关的分子标记的克隆及应用
GB0902793D0 (en) 2009-02-20 2009-04-08 Univ Gent GDF15 as molecular tool to monitor and enhance phenotypic stability of articular chondrocytes
EP3872168A1 (en) * 2020-02-28 2021-09-01 Cline Scientific AB Chondrocyte differentiation
KR20230052963A (ko) 2020-08-21 2023-04-20 젠자임 코포레이션 Fgfr3 항체 및 사용 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837258A (en) * 1991-08-30 1998-11-17 University Of South Florida Induction of tissue, bone or cartilage formation using connective tissue growth factor
US5723331A (en) 1994-05-05 1998-03-03 Genzyme Corporation Methods and compositions for the repair of articular cartilage defects in mammals
US5902785A (en) * 1995-06-06 1999-05-11 Genetics Institute, Inc. Cartilage induction by bone morphogenetic proteins
JPH11507828A (ja) 1995-06-12 1999-07-13 イエーダ リサーチ アンド ディベロップメント カンパニー,リミテッド Fgfr3に対して特異的なリガンドとしてのfgf9
AU742342B2 (en) 1997-05-21 2001-12-20 Clontech Laboratories, Inc. Nucleic acid arrays
WO1998059035A2 (en) 1997-06-25 1998-12-30 The Goverment Of The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services, National Institutes Of Health Serum-free cell growth medium
DK1282690T3 (da) * 1999-10-06 2005-02-28 Tigenix Nv Isolation af precursorceller og anvendelse deraf til vævsreparation
PT1218037E (pt) * 1999-10-06 2005-05-31 Tigenix Nv Ensaios in vitro e marcadores moleculares para testar a estabilidade fenotipica de populacoes de celulas, e populacoes de celulas seleccionadas para transplantacao autologa
US7482114B2 (en) 1999-10-06 2009-01-27 Tigenix N.V. In vivo assay and molecular markers for testing the phenotypic stability of cell populations, and selected cell populations for autologous transplantation

Also Published As

Publication number Publication date
EP1498146A2 (en) 2005-01-19
EP1218037B1 (en) 2004-12-29
EP1218037A2 (en) 2002-07-03
CA2397610A1 (en) 2001-04-12
CY2010007I2 (el) 2010-07-28
AU7764200A (en) 2001-05-10
CY2010007I1 (el) 2010-07-28
DE20023659U1 (de) 2005-07-07
PT1218037E (pt) 2005-05-31
US7479367B1 (en) 2009-01-20
DE122010000021I1 (de) 2012-09-06
CA2397610C (en) 2012-07-03
ES2234673T3 (es) 2005-07-01
US9089598B2 (en) 2015-07-28
LU91672I2 (fr) 2010-06-02
WO2001024833A2 (en) 2001-04-12
DE60017159T2 (de) 2006-05-04
ATE285797T1 (de) 2005-01-15
EP1498146A3 (en) 2007-01-24
DE60017159D1 (de) 2005-02-03
ES2488240T1 (es) 2014-08-26
US20090162328A1 (en) 2009-06-25
WO2001024833A3 (en) 2001-12-20

Similar Documents

Publication Publication Date Title
LU91672I2 (fr) ChondroCelect
Yamasaki et al. Meniscal regeneration using tissue engineering with a scaffold derived from a rat meniscus and mesenchymal stromal cells derived from rat bone marrow
SE9303977D0 (sv) Verfahren zur herstellung von implantatkeramikmaterial, insbesonders von hydroxylapatit aufweisenden implantatkeramikmaterial
ATE213590T1 (de) Fgf9 als spezifischer ligand für fgfr3
DE69028678D1 (de) Maytansinoid enthaltende cytotoxische Mittel und ihre therapeutische Anwendung
YU12201A (sh) Metodi, instrumenti i materijali za transplantaciju ćelija hondrocita
CY1109742T1 (el) Μεθοδοι και συνθεσεις για επουλωση και αποκατασταση αρθρικου χονδρου
BR0214217A (pt) Aumento de função de órgão
DE69934179D1 (de) Zusammensetzung enthaltend, ein Antigen, ein TH-1 induzierendes Adjuvans und eine im Wasser schwer lösliche Aminosäure, zur Verwendung in der Immunisierung
DE60113570D1 (de) Spritzgusspolymer
ATE429450T1 (de) Chimärische dr4 antikörper und ihre verwendung
ATE203021T1 (de) Verwendung von lactamverbindungen als pharmazeutische wirkstoffe
DK87190A (da) Fremgangsmaade til at regulere plantevaekst under anvendelse af svovlholdige organiske syrer
DK2359854T3 (da) Farmaceutiske sammensætninger og fremgangsmåder egnet til modulering af angiogenese
ID30073A (id) Metode untuk menyambung, menandai dan memodifikasi secara struktural monofilamen-monofilamen
DE60034672D1 (de) Reporterverbindungen und verfahren zur bestimmung des lipidisierungsstatus einer zelle
DE59507162D1 (de) Verfahren zur Befestigung von Hängen
ES2151895T3 (es) Procedimiento para la obtencion de cultivos celulares con alto contenido en citoquinas endogenas.
ATE481641T1 (de) Verfahren zur fixierung eines proteins auf einem pyrrolpolymerisat, und dessen verwendung zur herstellung eines sensors
ATE455565T1 (de) Verwendung eines biologischen materials mit dreidimensionalen gerüsten aus hyaluronsäure- derivaten
EP1188821A4 (en) CARRIER FOR ANIMAL CELL CULTURE INCLUDING AN ORGAN TISSUE DISC AND ANIMAL CELL CULTURE METHOD AND TRANSPLANTATION METHOD USING SUCH A CARRIER
ATE172028T1 (de) Zytodiagnostisches verfahren unter verwendung von alstonin als selektivem marker und diesen marker enthaltender diagnostischer kit
ATE248218T1 (de) Humane hypertrophe chrondrozyten zelllinien
KR970701349A (ko) 치주 및 페리-임플런트 질환 활성의 마커로서의 피리디놀린 가교체
DE60022487D1 (de) In vivo färbemittel und verwendungsmethoden zur identifizierung von dysplastischem gewebe